Podcast Episodes
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Podcast Episode
10: Revisiting Seamless 2/3 Trial for GLP-1 Agonist
In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.
Podcast Episode
9: I-SPY 2 to GBM AGILE and Beyond
In this episode of "In the Interim...," we sit down with Dr. Meredith Buxton to explore the evolution of platform trials from I-SPY 2 to GBM AGILE and Beyond.
Podcast Episode
8: External Data in Clinical Trials
In this episode of "In the Interim...," Scott Berry and Kert Viele navigate the nuanced debate surrounding the integration of external data in clinical trials.
Podcast Episode
7: Remembering Jimmie Savage
In this episode of "In the Interim," Don Berry shares the life and work of Jimmie Savage, his advisor and a legendary figure in Bayesian statistics.
Podcast Episode
6: The Art and Slog of Innovating
In this compelling episode of "In the Interim," Dr. Mike Krams, a seasoned expert in clinical trials and drug development, joins us to discuss the art and slog of innovation in pharmaceutical companies.
Podcast Episode
5: Religion, Politics, and Ordinal Outcomes
In this episode of "In the Interim," Scott Berry discusses the vital topic of ordinal outcomes in clinical trials—a subject as controversial as politics and religion at the dinner table.
No results found.
There are no results with this criteria. Try changing your search.
